Medical Research

The promise of rapidly delivering life-saving treatments to patients is often mired in a complex web of regulation, but a series of ambitious reforms initiated by the Food and Drug Administration in 2025 sought to change that dynamic. Against a backdrop of a turbulent year for its parent agency,

The arduous journey from a promising scientific discovery to an approved medical treatment is fraught with financial peril, particularly for rare inherited conditions where market incentives are often misaligned with patient needs. Charcot-Marie-Tooth disease Type 1A (CMT1A), the most common form

A silent and pervasive threat is contaminating global water systems as pharmaceuticals, designed to be stable within the human body, prove to be equally resilient in the environment. Compounds like the antiepileptic drug carbamazepine are continuously released into waterways, bypassing conventional

The journey for a promising new drug from laboratory discovery to a patient's bedside can often span two decades, a timeline that represents a significant barrier to advancing public health and treating critical illnesses. This protracted and costly process is a widely acknowledged bottleneck in

The relentless progression of chronic cholestatic liver diseases, such as primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), presents a daunting challenge in modern medicine, where effective disease-modifying therapies remain frustratingly out of reach. For countless

Health authorities in Bangladesh have officially confirmed a local outbreak of the Zika virus, with ten laboratory-confirmed cases identified in and around the capital city of Dhaka between September and December 2024, providing conclusive evidence of domestic transmission and raising significant